Back to User profile » Dr Itasu Ninomiya
Papers published by Dr Itasu Ninomiya:
Peripheral Blood Platelet–Lymphocyte Ratio Is Good Predictor of Chemosensitivity and Prognosis in Gastric Cancer Patients
Ohe Y, Fushida S, Yamaguchi T, Kinoshita J, Saito H, Okamoto K, Nakamura K, Tajima H, Ninomiya I, Ohta T
Cancer Management and Research 2020, 12:1303-1311
Published Date: 20 February 2020
Multidisciplinary therapy for scirrhous gastric cancer: a retrospective analysis and proposal of new treatment strategy
Fushida S, Kinoshita J, Oyama K, Fujimura T, Tsukada T, Yamaguchi T, Ninomiya I, Ohta T
Cancer Management and Research 2018, 10:3833-3839
Published Date: 24 September 2018
Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial–mesenchymal transition and acts synergistically with 5-fluorouracil
Kurata T, Fushida S, Kinoshita J, Oyama K, Yamaguchi T, Okazaki M, Miyashita T, Tajima H, Ninomiya I, Ohta T
Cancer Management and Research 2018, 10:2729-2742
Published Date: 15 August 2018
The effect of HIF-1α and PKM1 expression on acquisition of chemoresistance
Okazaki M, Fushida S, Tsukada T, Kinoshita J, Oyama K, Miyashita T, Ninomiya I, Harada S, Ohta T
Cancer Management and Research 2018, 10:1865-1874
Published Date: 4 July 2018
VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer: prognostic significance of VEGF in ascites and efficacy of anti-VEGF monoclonal antibody
Fushida S, Oyama K, Kinoshita J, Yagi Y, Okamoto K, Tajima H, Ninomiya I, Fujimura T, Ohta T
OncoTargets and Therapy 2013, 6:1445-1451
Published Date: 16 October 2013